S.Amdt. 5379

SA 5379. Mr. WELCH submitted an amendment intended to be proposed by
him to the concurrent resolution S. Con. Res. 33, setting forth the
congressional budget for the United States Government for fiscal year
2026 and setting forth the appropriate budgetary levels for fiscal
years 2027 through 2035; which was ordered to lie on the table; as
follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO
REDIRECTING AND RESCINDING CERTAIN FUNDS
APPROPRIATED UNDER THE ONE BIG BEAUTIFUL BILL
ACT, SO THAT BLOCKBUSTER ORPHAN DRUGS AREN'T
EXEMPT FROM MEDICARE DRUG PRICE NEGOTIATION.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
redirecting and rescinding certain funds appropriated under
Public Law 119-21 (commonly known as the ``One Big Beautiful
Bill Act''), so that Blockbuster orphan drugs aren't exempt
from Medicare drug price negotiation, which may include
repealing section 71203 of such Act to ensure that Medicare
can negotiate drug prices for rare disease drugs when
Medicare spending exceeds $400,000,000 annually on that drug,
regardless of the drug's orphan status, and paying for such
repeal by rescinding funds appropriated under sections 90003
and 100052 of such Act, including rescinding funds
appropriated for the Department of Homeland Security,
Immigration and Customs Enforcement, or Customs and Border
Patrol, by the amounts provided in such legislation for those
purposes, provided that such legislation would not increase
the deficit over the period of the total of fiscal years 2026
through 2035.
______